← FDA DRUG APPROVALS

FDA NDA · NDA005319

PANTOPAQUE

Sponsor: ALCON

APPLICATION
NDA005319
TYPE
NDA
LATEST ACTION
1980-07-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PANTOPAQUEDiscontinued
IOPHENDYLATE 100% · INJECTABLE · INJECTION

Approval history

1980-07-21Labeling · Supplement 9AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →